Cancer Capitalism: How Drug Companies and Health Providers Profit
Leading to overcharges, treatments that don’t extend lives and failed implants.
This article is for subscribers only.
Hi, it’s Bob and John in New York. Bloomberg News has spent the year looking at the business of cancer, from how pharmaceutical companies bring drugs to market to how much they cost when hospitals administer them. More on that in a moment, but first …
Oncology was once a backwater of drug research. Over the last few decades it’s become a booming business that drives at least $200 billion a year in sales for drugmakers globally.